The (Statistical) Power and the Glory
The worst possible outcome from a clinical trial is a negative result with a drug that actually ...

Why killing “above average” projects is the only way to rescue biotech’s return on investment
Across the whole sector, the return on investment in biotech (broadly defined to encompass ...